Eupraxia Pharmaceuticals Inc. (EPRX.TO) TSX

11.68

+0.5(+4.47%)

Updated at February 20 04:00PM

Currency In CAD

Valuation

Market Cap153.03M
Enterprise Value120.03M
P/E Ratio-11.12
PEG Ratio1.38
Price/Sales Ratio0
Price/Book Ratio3.12
Enterprise/Revenue0
Enterprise/EBITDA-9.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.63

Income Statement

Revenue0
Revenue/Share0
Gross Profit-235,248
EBITDA-33.72M
Net Income-34.94M
Diluted EPS-1.03

Balance Sheet

Total Cash123.78M
Total Cash/Share3.7
Total Debt237,385
Total Debt/Equity0
Current Ratio23.98
Book Value Per Share3.68

Price History

52-Week Change130.83
52-Week High12.86
52-Week Low3.96
Moving Average 50 Days10.64
Moving Average 200 Days8.08

Statistics

Average Volume78,813
Shares Outstanding35.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A